摘要
目的评价2011年至2013年成都地区医院抗肿瘤药物的使用状况。方法采用限定日剂量(DDD)方法,对成都地区21家医院2011年至2013年抗肿瘤用药的销售金额、用药频度(DDDs)等进行统计和分析。结果 2011年至2013年成都地区21家医院抗肿瘤药物销售药总金额分别为44 251.74,52 401.03,67 884.02万元。亚类金额排序和用药频度排序前列中,主要包括抗植物来源抗肿瘤药物和其他类抗肿瘤药物等。结论成都地区医院抗肿瘤用药呈快速增长趋势,建议临床医师选择疗效确切、不良反应少、价格便宜的抗肿瘤药物,以减少患者经济负担。
Objective To evaluate tbe use situation of antineoplastic drugs in Cbengdu area during 2011-2013. Methods Tbe con-sumption amount and DDDs of antineoplastic drugs in 21 bospitals of Cbengdu area during 2011-2013 were statistically analyzed by using tbe DDD metbod. Results Tbe total consumption amounts of tbe antineoplastic drugs in 21 bospitals of Cbengdu area during 2011-2013 were 44 251. 74,52 401. 03,67 884. 02 million Yuan respectively. Tbe antineoplastic drugs derived from plants and otber antineoplastic agents took tbe main position in tbe sum and DDDs ranking. Conclusion Tbe antineoplastic drugs in bospitals of Cbeng-du area present a rapid increase tendency. It is suggested tbat tbe clinical pbysicians select tbe antineoplastic drugs witb definite effica-cy,few adverse reactions and cbeap price for reducing tbe economic burden of patients.
出处
《中国药业》
CAS
2015年第16期124-126,共3页
China Pharmaceuticals
